| Literature DB >> 26905719 |
Laurent Bessemans1, Vanessa Jully2, Caroline de Raikem2, Mathieu Albanese3, Nicolas Moniotte2, Pascal Silversmet2, Dominique Lemoine2.
Abstract
High-throughput screening technologies are increasingly integrated into the formulation development process of biopharmaceuticals. The performance of liquid handling systems is dependent on the ability to deliver accurate and precise volumes of specific reagents to ensure process quality. We have developed an automated gravimetric calibration procedure to adjust the accuracy and evaluate the precision of the TECAN Freedom EVO liquid handling system. Volumes from 3 to 900 µL using calibrated syringes and fixed tips were evaluated with various solutions, including aluminum hydroxide and phosphate adjuvants, β-casein, sucrose, sodium chloride, and phosphate-buffered saline. The methodology to set up liquid class pipetting parameters for each solution was to split the process in three steps: (1) screening of predefined liquid class, including different pipetting parameters; (2) adjustment of accuracy parameters based on a calibration curve; and (3) confirmation of the adjustment. The run of appropriate pipetting scripts, data acquisition, and reports until the creation of a new liquid class in EVOware was fully automated. The calibration and confirmation of the robotic system was simple, efficient, and precise and could accelerate data acquisition for a wide range of biopharmaceutical applications.Entities:
Keywords: High-throughput screening; fixed tips; instrumentation qualification; robotics and instrumentation; systems; visual basic
Mesh:
Year: 2016 PMID: 26905719 PMCID: PMC5030733 DOI: 10.1177/2211068216632349
Source DB: PubMed Journal: J Lab Autom ISSN: 2211-0682
Configuration Parameters of Predefined Liquid Classes.
| Subclass | Aspiration Parameters | Dispensing Parameters | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Liquid Class | No. | Volumes (µL) | Aspirate speed (µL/s) | Delay (ms) | STAG | LAG | TAG | Dispense Speed | Break-Off Speed | Factor | Offset |
| DMSO | 1 | 3.00–15.01 | 20 | 200 | 10 | 10 | 5 | 600 | 150 | 1.063 | 0.10 |
| 2 | 15.01–200.01 | 100 | 200 | 20 | 0 | 10 | 1.100 | −0.30 | |||
| 3 | 200.01–1000.01 | 150 | 300 | 20 | 0 | 10 | 1.002 | 19.30 | |||
| Water | 1 | 3.00–15.01 | 20 | 200 | 10 | 10 | 5 | 1.045 | 0.20 | ||
| 2 | 15.01–500.01 | 150 | 200 | 20 | 0 | 10 | 1.042 | −0.04 | |||
| 3 | 500.01–1000.01 | 150 | 200 | 20 | 0 | 10 | 1.000 | 20.26 | |||
| Serum | 1 | 3.00–15.01 | 20 | 200 | 10 | 20 | 10 | 1.074 | 0.30 | ||
| 2 | 15.01–300.01 | 100 | 200 | 20 | 0 | 10 | 1.060 | 0.43 | |||
| 3 | 300.01–1000.01 | 100 | 200 | 20 | 0 | 10 | 1.007 | 16.63 | |||
| Ethanol | 1 | 3.00–1000.01 | 100 | 200 | 20 | 0 | 10 | 1.063 | 3.4 | ||
| Liquid system | 1 | 3.00–1000.01 | 150 | 200 | 0 | 0 | 10 | 1.000 | 0 | ||
LAG, leading air gap; STAG, system trailing air gap; TAG, trailing air gap.
Figure 1.Liquid class air gap setting configurations used for default liquid class.
Figure 2.Flow diagram of predefined liquid class screening.
Acceptance Criteria Used in Assessing Performance.
| Subclass 1 | Subclass 2 | Subclass 3 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Volume No. | 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 |
| Serum | 15% DEV | 10% DEV | 8% DEV | 7% DEV | 2% DEV | 1% DEV | 1% DEV | 0.5% DEV | 0.5% DEV |
| DMSO | 10% DEV | 4% DEV | 2% DEV | ||||||
| Water | 7% DEV | 1% DEV | 0.5% DEV | 0.5% DEV | |||||
AH, aluminum hydroxide adjuvant; AP, aluminum phosphate adjuvant; CV, coefficient of variation; % DEV, deviation expressed in percent.
Figure 3.Flow diagram of adjustment.
Figure 4.Flow diagram of confirmation process.
Figure 5.Screening of default liquid class for single dispensing of aluminum phosphate adjuvant using a 300 µL pipetting, with volumes measured gravimetrically. Ethanol (•), DMSO (○), serum (■), water (◊), liquid system (▲).
Screening of Default Liquid Classes.
| Solvent | Water-Free Dispense | Serum-Free Dispense | DMSO-Free Dispense | Ethanol-Free Dispense | System Liquid-Free Dispense | |
|---|---|---|---|---|---|---|
| AP | Mean volume | 291.7 | 295.4 | 298.5 | 298.9 | 288.9 |
| Min volume | 290.7 | 294.6 | 296.6 | 296.6 | 287.8 | |
| Max volume | 293.7 | 296.6 | 299.5 | 300.5 | 289.8 | |
| DEV (%) | −2.76 | −1.54 |
| −0.37 | −3.70 | |
| CV (%) | 0.31 |
| 0.35 | 0.46 | 0.28 | |
| Sucrose | Mean volume | 287.4 | 292.6 | 294.6 | 296.6 | 284.1 |
| Min volume | 285.7 | 290.8 | 294.1 | 295.8 | 282.4 | |
| Max volume | 289.1 | 294.1 | 295.8 | 297.5 | 285.7 | |
| DEV (%) | −4.20 | −2.45 |
| −1.12 | −5.29 | |
| CV (%) | 0.35 | 0.37 |
| 0.21 | 0.37 | |
| β-Casein | Mean volume | 297.7 | 301.3 | 305.4 | 305.2 | 287.0 |
| Min volume | 295.7 | 299.6 | 303.6 | 303.4 | 283.5 | |
| Max volume | 299.9 | 302.6 | 307.1 | 306.6 | 289.9 | |
| DEV (%) | −0.75 |
| 1.81 | 1.74 | −4.33 | |
| CV (%) | 0.48 |
| 0.43 | 0.38 | 0.72 | |
| PBS | Mean volume | 298.5 | 302.1 | 305.3 | 305.8 | 291.3 |
| Min volume | 297.1 | 300.0 | 303.9 | 302.9 | 286.3 | |
| Max volume | 300.0 | 303.9 | 306.9 | 308.8 | 298.0 | |
| DEV (%) |
| 0.69 | 1.76 | 1.92 | −2.90 | |
| CV (%) |
| 0.40 | 0.34 | 0.58 | 1.56 | |
| AH | Mean volume | 291.5 | 296.9 | 299.2 | 300.6 | 289.3 |
| Min volume | 290.8 | 295.7 | 297.6 | 299.6 | 287.8 | |
| Max volume | 291.7 | 297.6 | 300.6 | 301.6 | 290.8 | |
| DEV (%) | −2.83 | −1.03 |
| 0.20 | −3.57 | |
| CV (%) |
| 0.29 | 0.35 | 0.30 | 0.36 | |
| NaCl | Mean volume | 292.1 | 295.9 | 299.2 | 298.9 | 286.6 |
| Min volume | 290.2 | 294.4 | 297.7 | 297.7 | 285.1 | |
| Max volume | 292.7 | 296.9 | 300.3 | 299.4 | 287.6 | |
| DEV (%) | −2.65 | −1.35 |
| −0.37 | −4.47 | |
| CV (%) | 0.30 | 0.32 |
| 0.21 | 0.38 | |
AH, aluminum hydroxide adjuvant; AP, aluminium phosphate adjuvant; CV, coefficient of variation; % DEV, deviation expressed in % PBS, phosphate buffer saline.
TECAN Freedom EVO 200 Performance as Measured by the Gravimetric Approach.
| Solvent | Default LC | Run | Target Volume | Mean Volume | DEV (%) | CV (%) | Factor ( | Offset ( |
|---|---|---|---|---|---|---|---|---|
| AP | Serum | A1 | 16.0 | 16.1 | 0.61 | 3.24 | ||
| C | 16.0 | 15.9 | 0.91 | 2.85 | ||||
| A1 | 158.0 | 155.9 | 1.36 | 0.65 | 1.060 | 0.43 | ||
| C | 158.0 | 157.9 | 0.05 | 0.52 | 1.075 | 0.68 | ||
| A1 | 300.0 | 295.1 | 1.63 | 0.25 | ||||
| C | 300.0 | 300.1 | 0.04 | 0.30 | ||||
| A1 | 301.0 | 297.6 | 1.14 | 0.66 | ||||
| C | 301.0 | 299.6 | 0.45 | 0.47 | ||||
| A1 | 601.0 | 600.2 | 0.13 | 0.24 | 1.007 | 16.63 | ||
| C | 601.0 | 601.8 | 0.14 | 0.10 | 1.003 | 21.36 | ||
| A1 | 900.0 | 898.3 | 0.19 | 0.23 | ||||
| C | 900.0 | 899.6 | 0.04 | 0.16 | ||||
| Sucrose | DMSO | A1 | 16.0 | 14.5 | 9.40 | 4.10 | ||
| C | 16.0 | 17.3 | 8.32 | 3.61 | ||||
| A1 | 108.0 | 101.1 | 6.43 | 0.59 | 1.100 | 0.30 | ||
| C | 108.0 | 104.1 | 3.61 | 0.52 | 1.103 | 3.67 | ||
| A1 | 200.0 | 197.2 | 1.42 | 0.51 | ||||
| C | 200.0 | 201.6 | 0.79 | 0.47 | ||||
| A1 | 201.0 | 198.3 | 1.33 | 0.55 | ||||
| C | 201.0 | 200.8 | 0.08 | 0.45 | ||||
| A1 | 551.0 | 538.6 | 2.26 | 0.15 | 1.002 | 19.30 | ||
| C | 551.0 | 551.5 | 0.09 | 0.21 | 1.031 | 16.07 | ||
| A1 | 900.0 | 877.5 | 2.50 | 0.17 | ||||
| C | 900.0 | 899.4 | 0.07 | 0.20 | ||||
| β-Casein | Serum | A1 | 3.0 | 2.6 | 13.61 | 8.54 | ||
| C | 3.0 | 2.8 | 6.58 | 8.19 | ||||
| A1 | 9.0 | 8.5 | 6.03 | 1.21 | 1.074 | 0.30 | ||
| C | 9.0 | 8.7 | 3.69 | 2.66 | 1.078 | 0.74 | ||
| A1 | 15.0 | 14.6 | 2.94 | 1.49 | ||||
| C | 15.0 | 15.1 | 0.78 | 1.44 | ||||
| A1 | 16.0 | 15.5 | 2.96 | 8.03 | ||||
| C | 16.0 | 15.4 | 3.82 | 7.18 | ||||
| A1 | 158.0 | 159.4 | 0.87 | 0.44 | 1.060 | 0.43 | ||
| C | 158.0 | 158.4 | 0.28 | 0.47 | 1.052 | 0.75 | ||
| A1 | 300.0 | 301.6 | 0.54 | 0.41 | ||||
| C | 300.0 | 299.8 | 0.07 | 0.36 | ||||
| A1 | 301.0 | 302.8 | 0.60 | 0.26 | ||||
| C | 301.0 | 301.6 | 0.21 | 0.26 | ||||
| A1 | 601.0 | 600.2 | 0.13 | 0.21 | 1.007 | 16.63 | ||
| C | 601.0 | 600.0 | 0.16 | 0.24 | 1.011 | 14.11 | ||
| A1 | 900.0 | 899.4 | 0.07 | 0.20 | ||||
| C | 900.0 | 899.9 | 0.01 | 0.19 |
AP, aluminum phosphate adjuvant; A, adjustment; C, confirmation; CV, coefficient of variation; % DEV, deviation expressed in % LC, liquid class.
TECAN Freedom EVO 200 Performance as Measured by the Gravimetric Approach.
| Solvent | Default LC | Run | Target Volume | Mean Volume | DEV (%) | CV (%) | Factor ( | Offset ( |
|---|---|---|---|---|---|---|---|---|
| PBS | Water | A1 | 3.0 | 2.3 | 22.79 | 10.84 | ||
| C | 3.0 | 3.2 | 6.62 | 10.22 | ||||
| A1 | 9.0 | 8.0 | 11.2 | 8.99 | 1.045 | 0.20 | ||
| C | 9.0 | 9.2 | 2.26 | 4.88 | 1.027 | 1.29 | ||
| A1 | 15.0 | 13.9 | 7.35 | 10.76 | ||||
| C | 15.0 | 15.0 | 0.08 | 1.42 | ||||
| A1 | 16.0 | 15.8 | 1.19 | 3.97 | ||||
| C | 16.0 | 16.2 | 1.10 | 3.24 | ||||
| A1 | 258.0 | 256.7 | 0.49 | 0.24 | 1.042 | 0.04 | ||
| C | 258.0 | 257.4 | 0.25 | 0.41 | 1.043 | 0.40 | ||
| A1 | 500.0 | 506.9 | 0.15 | 0.81 | ||||
| C | 500.0 | 498.9 | 0.22 | 0.31 | ||||
| A1 | 501.0 | 499.9 | 0.22 | 0.62 | ||||
| C | 501.0 | 501.7 | 0.14 | 0.89 | ||||
| A1 | 701.0 | 697.9 | 0.44 | 0.24 | 1.000 | 20.26 | ||
| C | 701.0 | 701.5 | 0.07 | 0.26 | 1.007 | 18.79 | ||
| A1 | 900.0 | 895.1 | 0.54 | 0.20 | ||||
| C | 900.0 | 899.6 | 0.04 | 0.25 | ||||
| AH | DMSO | A1 | 3.0 | 2.4 | 19.78 | 3.78 | ||
| C | 3.0 | 2.9 | 3.41 | 7.69 | ||||
| A1 | 9.0 | 8.1 | 10.50 | 2.52 | 1.063 | 0.10 | ||
| C | 9.0 | 9.2 | 1.92 | 3.62 | 1.164 | 0.51 | ||
| A1 | 15.0 | 13.5 | 10.20 | 1.89 | ||||
| C | 15.0 | 15.1 | 0.52 | 2.26 | ||||
| A1 | 16.0 | 15.9 | 0.69 | 18.61 | ||||
| C | 16.0 | 16.9 | 5.75 | 1.91 | ||||
| A1 | 108.0 | 102.7 | 4.88 | 1.04 | 1.100 | 0.30 | ||
| C | 108.0 | 106.2 | 1.68 | 2.80 | 1.094 | 2.67 | ||
| A1 | 200.0 | 199.6 | 0.21 | 0.93 | ||||
| C | 200.0 | 200.5 | 0.26 | 0.19 | ||||
| A1 | 201.0 | 200.3 | 0.36 | 0.31 | ||||
| C | 201.0 | 199.8 | 0.61 | 0.52 | ||||
| A1 | 551.0 | 550.1 | 0.59 | 0.25 | 1.002 | 19.30 | ||
| C | 551.0 | 550.2 | 0.14 | 0.36 | 1.012 | 17.31 | ||
| A1 | 900.0 | 895.87 | 0.68 | 0.17 | ||||
| C | 900.0 | 899.6 | 0.05 | 0.16 | ||||
| NaCl | DMSO | A1 | 3.0 | 2.47 | 17.65 | 8.13 | ||
| C | 3.0 | 2.9 | 2.58 | 9.20 | ||||
| A1 | 9.0 | 7.76 | 13.79 | 3.79 | 1.063 | 0.10 | ||
| C | 9.0 | 8.8 | 2.00 | 1.39 | 1.218 | 0.36 | ||
| A1 | 15.0 | 12.97 | 13.51 | 1.72 | ||||
| C | 15.0 | 15.3 | 1.70 | 2.34 | ||||
| A1 | 16.0 | 15.7 | 2.10 | 6.38 | ||||
| C | 16.0 | 16.0 | 0.13 | 3.98 | ||||
| A1 | 108.0 | 110.7 | 2.50 | 0.39 | 1.100 | 0.30 | ||
| C | 108.0 | 108.1 | 0.07 | 0.59 | 1.072 | 0.64 | ||
| A1 | 200.0 | 204.3 | 2.13 | 0.56 | ||||
| C | 200.0 | 200.0 | 0.02 | 0.37 | ||||
| A1 | 201.0 | 206.5 | 2.72 | 0.22 | ||||
| C | 201.0 | 202.0 | 0.48 | 0.47 | ||||
| A1 | 551.0 | 544.8 | 1.13 | 0.28 | 1.002 | 19.30 | ||
| C | 551.0 | 548.8 | 0.40 | 0.31 | 1.028 | 9.00 | ||
| A1 | 900.0 | 887.8 | 1.35 | 0.16 | ||||
| C | 900.0 | 900.7 | 0.07 | 0.17 |
A, adjustment; AH, aluminum hydroxide adjuvant; C, confirmation; CV, coefficient of variation; % DEV, deviation expressed in % LC, liquid class; PBS, phosphate buffer saline.
Adsorption Capacity of Aluminum Phosphate Adjuvants.
| Columns | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Mean | SD | CV (%) | |
| Plate 1 | 4.43 | 4.33 | 4.32 | 4.26 | 4.32 | 4.34 | 4.16 | 4.60 | 4.29 | 4.41 | 4.53 | 4.29 | 4.36 | 0.12 | 2.73 |
| Plate 2 | 4.36 | 4.21 | 4.61 | 4.17 | 4.48 | 4.39 | 4.25 | 4.19 | 4.15 | 4.03 | 4.00 | 4.36 | 4.27 | 0.18 | 4.24 |
| Mean | 4.40 | 4.27 | 4.47 | 4.21 | 4.40 | 4.37 | 4.21 | 4.39 | 4.22 | 4.22 | 4.26 | 4.33 | |||
| SD | 0.05 | 0.09 | 0.20 | 0.07 | 0.12 | 0.04 | 0.06 | 0.29 | 0.10 | 0.27 | 0.38 | 0.05 | |||
| CV (%) | 1.17 | 2.05 | 4.58 | 1.58 | 2.63 | 0.83 | 1.46 | 6.56 | 2.38 | 6.38 | 8.88 | 1.17 | |||
CV, coefficient of variation; SD, standard deviation.
Surface Phosphophilicity of Aluminum Hydroxide Adjuvant.
| Columns | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Mean | SD | CV (%) | |
| Row 1 | 44.9 | 45.1 | 46.9 | 49.7 | 44.1 | 44.9 | 47.9 | 42.8 | 46.3 | 50.2 | 54.5 | 50.5 | 47.3 | 3.4 | 7.1 |
| Row 2 | 53.1 | 53.0 | 53.3 | 46.6 | 46.7 | 54.8 | 51.6 | 49.0 | 47.4 | 48.6 | 46.7 | 45.5 | 49.7 | 3.3 | 6.6 |
| Row 3 | 48.0 | 51.6 | 51.1 | 48.6 | 53.4 | 53.7 | 57.2 | 44.8 | 40.5 | 51.5 | 53.4 | 50.0 | 50.3 | 4.4 | 8.8 |
| Row 4 | 50.6 | 51.2 | 49.3 | 44.7 | 50.0 | 52.0 | 51.1 | 54.6 | 54.3 | 57.7 | 54.9 | 41.5 | 51.0 | 4.5 | 8.8 |
| Row 5 | 45.1 | 56.9 | 54.6 | 56.6 | 56.4 | 54.2 | 48.2 | 46.1 | 50.7 | 55.1 | 52.3 | 52.8 | 52.4 | 4.1 | 7.8 |
| Row 6 | 53.7 | 55.0 | 58.9 | 43.6 | 48.7 | 59.5 | 54.8 | 50.6 | 52.8 | 55.7 | 56.4 | 46.8 | 53.0 | 4.8 | 9.1 |
| Row 7 | 46.8 | 53.1 | 52.1 | 53.3 | 55.0 | 54.0 | 56.4 | 43.9 | 43.1 | 49.4 | 53.6 | 50.6 | 50.9 | 4.3 | 8.5 |
| Row 8 | 47.5 | 49.3 | 48.3 | 45.4 | 47.0 | 50.1 | 49.6 | 45.9 | 48.4 | 48.1 | 52.6 | 49.7 | 48.5 | 2.0 | 4.0 |
| Mean | 48.7 | 51.9 | 51.8 | 48.6 | 50.2 | 52.9 | 52.1 | 47.2 | 48.0 | 52.0 | 53.0 | 48.4 | |||
| SD | 3.4 | 3.6 | 3.9 | 4.5 | 4.4 | 4.2 | 3.6 | 3.9 | 4.7 | 3.6 | 2.9 | 3.6 | |||
| CV (%) | 7.0 | 6.9 | 7.4 | 9.2 | 8.8 | 7.9 | 7.0 | 8.3 | 9.8 | 7.0 | 5.5 | 7.5 | |||
CV, coefficient of variation; SD, standard deviation.